Giuliana Miglierini
Crystals of high quality
The capacity to obtain high quality active ingredients in the crystalline form is crucial to ensure the technological and performance profile of the finished medicinal product. We discussed with the experts the main features of a good crystallisation process
Health inspections and controls on medicines
Several medicinal products are subjected to Custom controls upon their arrival at the destination airport. USMAF is the Italian health inspector authority responsible for such controls at the Italian borders
Drug interactions deserve deeper attention
Treatment guidelines currently in use are generally based on mono-therapies. The debate is open as for the need to consider also drug interactions, a frequent occurrence in polytherapy regimes
A special chance for innovation and investments
The unique macroeconomical framework should help the Italian manufacturers of pharmaceutical raw materials to strengthen their leading position in the field. Investments and institutional support is needed to overcome the bottlenecks that still slow down foreign investments in Italy. The president of Aschimfarma Gian Mario Baccalini comments the current trends.
A safe environment for safe drugs
The clear room validation is a critical point in the global validation of the production process for sterile drugs. Many factors should be considered, together with accurate risk analysis and process planning. Future might see different approaches to clean room validationNewsstand
-
NCF International 2024
-
NCF International 2023